Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole maintenance treatment in adults with schizophrenia
2011-005766-38Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Brexpiprazole maintenance with Placebo (2 arms). Primary endpoint: Time from randomization to exacerbation of psychotic symptoms or impending relapse. Started Dec 2012; status: completed.
02
Drugs
brexpiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2011-005766-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005766-38.